Monoclonal antibodies of hybridomas.
Among the most prominent biological advances of this century, the hybridoma technology stands out as providing the best tool for the analysis of complex antigens of pathogens and tumor cells. This technology will play a major role in the immunodiagnosis and treatment of infectious and malignant diseases. This review focuses on the most recent developments (1980-1981), with emphasis on human immunology.
D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology; D002277:Carcinoma / Q000276:immunology; D005260:Female; D006801:Humans; D006825:Hybridomas / Q000276:immunology*; D007938:Leukemia / Q000276:immunology; D009052:Leukemia Virus, Murine; D007942:Leukemia, Experimental / Q000276:immunology; D008223:Lymphoma / Q000276:immunology; D008325:Mammary Neoplasms, Experimental / Q000276:immunology; D008545:Melanoma / Q000276:immunology; D008722:Methods; D051379:Mice; D008875:Middle Aged; D012509:Sarcoma / Q000276:immunology
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm